biosilk biospecificity biostar p31 biosynthetic pharmace biosystems biotsrespiration biotechnology action biotechnology and new biotechnology frontie biotechnology venture biotelescanner bioticclimax biotite hypersthene t biotoecus opercularis bioviscoelastic bioyield bipalm ately compound bipartition angle biphasic...
making cash instruments less appealing and pharma corporations will still need to replenish product pipelines. Those are among the reasons why some traditional drug makers could opt to strike while biotech valuations are low and most of the stocks in the industry are dithering. ...
4.2.4 Big data handling of pharma data A huge repository of data is generated in terabytes and petabytes from modern digital technologies, cloud computing, and IoT, and the analysis of this data is required for decision-making at multiple levels. The main aim of big data analysis is to proc...
Big Pharma Stocks Retail Stocks Top Indexes Dow Jones S&P 500 Nasdaq Gold Bitcoin Market Outlook Today's Market US Economy Gold & Precious Metals Commodities Forex Editors' Picks Cryptocurrency Market Data Bond ETFs Commodity ETFs Country ETFs ...
For the iShares FTSE/Xinhua China 25 Index (NYSEARCA:FXI) the impact has been especially pronounced, as theETF's holdings are denominated in the Hong Kong Dollar. As global trade war worries have heated up, the United States market and the U.S. Dollar have seemed still like the best pla...
As AstraZeneca looks to climb toward the top of biopharma companies by revenue by the end of the decade, smaller companies are looking to join the ranks of the unofficial Big Pharma club.
The talk of a global trade war instigated by the US surely cannot be helping any multinational company like a big pharma group. Meanwhile the sector-specific risk of US government action to limit drug price increases still haunts investors, and rhetoric could intensify as the November mid-term ...
The Swiss pharma giant is developing multiple GLP-1 weight loss drugs that have been showing promise in early-stage trials. One is CT-388, which is a weekly injectable, similar to the approved GLP-1 treatments on the market today. In an early-stage trial, it has helped people ...
How do we leverage the on-market data to support performance of your diagnostic test or genomic panel This event will be covered by the LPBI Group on Twitter. Follow on @Pharma_BI @StephenJWillia2 @Aviva1950 @AdvancingPM using the following meeting hashtags ...
Back at Verseon, Mr Kita says pharma has been slower than other industries to embrace this kind of cross-disciplinary working. “Your car was designed by computer. Your aeroplane was designed by computer. The pharma industry has been a holdout against that trend.” ...